Alaethes Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Alaethes Wealth’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-27,263	Closed	-$1.48M	–	110
2024 Q1	$1.48M	Buy	27,263 +10,071	+59%	+$513K	0.65%	64
2023 Q4	$882K	Sell	17,192 -615	-3%	-$32.3K	0.42%	88
2023 Q3	$1.03M	Buy	17,807 +2,408	+16%	+$148K	0.57%	75
2023 Q2	$985K	Buy	15,399 +600	+4%	+$40.2K	0.54%	76
2023 Q1	$1.03M	Buy	14,799 +1,269	+9%	+$89.5K	0.6%	71
2022 Q4	$973K	Buy	13,530 +733	+6%	+$55.3K	0.67%	65
2022 Q3	$910K	Buy	+12,797	New	+$928K	0.67%	64
2022 Q2	–	Sell	-24	Closed	-$2K	–	130
2022 Q1	$2K	Sell	24 -24	-50%	-$1.61K	﹤0.01%	271
2021 Q4	$3K	Hold	48	–	–	﹤0.01%	242
2021 Q3	$3K	Hold	48	–	–	﹤0.01%	232
2021 Q2	$3K	Buy	+48	New	+$3.13K	﹤0.01%	226

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alaethes Wealth's BMY Position: Q2 2024 in Review

Alaethes Wealth sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 27,263 shares — an estimated $1.48M sold.

Alaethes Wealth first reported a position in BMY in Q2 2021 and held it in 11 quarters. The position peaked at $1.48M in Q1 2024. 2,147 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

Alaethes Wealth reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
Alaethes Wealth sold 27,263 Bristol-Myers Squibb shares in Q2 2024, an estimated $1.48M.
Alaethes Wealth first reported a position in Bristol-Myers Squibb in Q2 2021 and held it in 11 quarters.
Alaethes Wealth's Bristol-Myers Squibb position peaked at $1.48M in Q1 2024.
2,147 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Alaethes Wealth's 13F filing for Q2 2024, filed 13 Aug 2024.